Table 2.
Controls (n = 55) | HT (n = 60) | DM + HT (n = 50) | P | |
---|---|---|---|---|
LVEDD (mm) | 46 ± 4 | 47 ± 5 | 48 ± 5 | .096 |
IVS (mm) | 9.0 ± 1.0 | 10.1 ± 1.2 a | 10.7 ± 1.3 a | <.001 |
PWT (mm) | 8.7 ± 1.0 | 9.5 ± 1.1 | 10.0 ± 1.0 | <.001* |
LAVI (mL/m2) | 26.7 ± 3.7 | 30.8 ± 4.0 a | 32.4 ± 4.4 a | <.001 |
LVMI (g/m2) | 70 ± 10 | 83 ± 12 | 92 ± 15 | <.001** |
EF (%) | 63 ± 3 | 62 ± 3 | 62 ± 3 | .134 |
E/A ratio | 1.11 ± 0.18 | 0.87 ± 0.23 a | 0.81 ± 0.20 a | <.001 |
E/e´ | 6.5 ± 2.3 | 9.3 ± 2.6 a | 9.8 ± 3.0 a | <.001 |
Abbreviations: A, late diastolic mitral flow (pulse Doppler); DM‐ type 2 diabetes mellitus; E, early diastolic mitral flow (pulsed Doppler); e′, average of the peak early diastolic relaxation velocity of the septal and lateral mitral annulus (tissue Doppler); EF, ejection fraction; HT, arterial hypertension; IVS, interventricular septum; LAVI, left atrial volume index; LVMI, left ventricular mass index; LVEDD, left ventricle end‐diastolic dimension; PWT, posterior wall thickness.
P < .01 vs controls.
P < .05 for all comparisons.
P < .01 for all comparisons.